Vaxcell-Bio Therapeutics Co., Ltd. (KOSDAQ:323990)
South Korea flag South Korea · Delayed Price · Currency is KRW
9,300.00
+100.00 (1.09%)
Oct 31, 2025, 1:40 PM KST

Vaxcell-Bio Therapeutics Market Cap

Vaxcell-Bio Therapeutics has a market cap or net worth of 213.97 billion as of October 30, 2025. Its market cap has decreased by -35.87% in one year.

Market Cap
213.97B
Enterprise Value
175.92B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
9,300.00

Market Cap Chart

Since September 22, 2020, Vaxcell-Bio Therapeutics's market cap has increased from 160.24B to 213.97B, an increase of 33.53%. That is a compound annual growth rate of 5.83%.

History

DateMarket Cap% Change
Oct 30, 2025213.97B-10.78%
Dec 30, 2024239.82B-53.54%
Dec 28, 2023516.20B-0.71%
Dec 29, 2022519.87B-21.31%
Dec 30, 2021660.68B-73.75%
Dec 30, 20202.52T1,470.89%
Sep 22, 2020 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition